These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 26990687

  • 1. Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension.
    Bissonnette J, Garcia-Pagán JC, Albillos A, Turon F, Ferreira C, Tellez L, Nault JC, Carbonell N, Cervoni JP, Abdel Rehim M, Sibert A, Bouchard L, Perreault P, Trebicka J, Trottier-Tellier F, Rautou PE, Valla DC, Plessier A.
    Hepatology; 2016 Jul; 64(1):224-31. PubMed ID: 26990687
    [Abstract] [Full Text] [Related]

  • 2. Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Patency Depends on Coverage and Interventionalist's Experience.
    Buechter M, Manka P, Gerken G, Canbay A, Blomeyer S, Wetter A, Altenbernd J, Kahraman A, Theysohn JM.
    Dig Dis; 2018 Jul; 36(3):218-227. PubMed ID: 29316565
    [Abstract] [Full Text] [Related]

  • 3. Transjugular Intrahepatic Portosystemic Shunt Placement During Pregnancy: A Case Series of Five Patients.
    Ingraham CR, Padia SA, Johnson GE, Easterling TR, Liou IW, Kanal KM, Valji K.
    Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1205-10. PubMed ID: 25613670
    [Abstract] [Full Text] [Related]

  • 4. Clinical outcome using the fluency stent graft for transjugular intrahepatic portosystemic shunt in patients with portal hypertension.
    Wu X, Ding W, Cao J, Fan X, Li J.
    Am Surg; 2013 Mar; 79(3):305-12. PubMed ID: 23461959
    [Abstract] [Full Text] [Related]

  • 5. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B, Zhao MF, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Dai S, Yao JN, Liu FQ.
    World J Gastroenterol; 2015 Nov 21; 21(43):12439-47. PubMed ID: 26604651
    [Abstract] [Full Text] [Related]

  • 6. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G, Benner KG, Saxon R, Barton RE, Rabkin J, Keller FS, Rosch J.
    Am J Gastroenterol; 1997 Sep 21; 92(9):1444-52. PubMed ID: 9317060
    [Abstract] [Full Text] [Related]

  • 7. Pregnancies after transjugular intrahepatic portosystemic shunt for noncirrhotic portal hypertension.
    Nicolas C, Ferrand E, d'Alteroche L, Ayoub J, Bastides F, Potin J, Perarnau JM.
    Eur J Gastroenterol Hepatol; 2014 Apr 21; 26(4):488-90. PubMed ID: 24526236
    [Abstract] [Full Text] [Related]

  • 8. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML, Asmacher S, Lehmann J, Jansen C, Görtzen J, Klein S, Meyer C, Strunk HM, Fimmers R, Tacke F, Strassburg CP, Trautwein C, Sauerbruch T, Wasmuth HE, Trebicka J.
    J Hepatol; 2015 Feb 21; 62(2):332-9. PubMed ID: 25457205
    [Abstract] [Full Text] [Related]

  • 9. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L.
    J Clin Gastroenterol; 2007 Feb 21; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
    Domagk D, Patch D, Dick R, Grosso M, Rousseau H, Otal P, Goffette P, Heinecke A, Drees M, Domschke W, Menzel J.
    Cardiovasc Intervent Radiol; 2002 Feb 21; 25(6):506-12. PubMed ID: 12183763
    [Abstract] [Full Text] [Related]

  • 12. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
    Haskal ZJ, Radhakrishnan J.
    J Vasc Interv Radiol; 2008 Apr 21; 19(4):516-20. PubMed ID: 18375295
    [Abstract] [Full Text] [Related]

  • 13. Feasibility and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in children.
    Di Giorgio A, Agazzi R, Alberti D, Colledan M, D'Antiga L.
    J Pediatr Gastroenterol Nutr; 2012 May 21; 54(5):594-600. PubMed ID: 22228077
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.
    Charon JP, Alaeddin FH, Pimpalwar SA, Fay DM, Olliff SP, Jackson RW, Edwards RD, Robertson IR, Rose JD, Moss JG.
    J Vasc Interv Radiol; 2004 Nov 21; 15(11):1219-30. PubMed ID: 15525740
    [Abstract] [Full Text] [Related]

  • 16. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G, Qi X, He C, Yin Z, Wang J, Xia J, Yang Z, Bai M, Meng X, Niu J, Wu K, Fan D.
    J Hepatol; 2011 Jan 21; 54(1):78-88. PubMed ID: 20932597
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [A comparison of efficacies between transjugular intrahepatic portosystemic shunt versus portoazygos devascularization in the treatment of portal hypertension with variceal bleeding].
    Xu XB, Chu JG, Huang H, Zhang HY, Zhang HY, Liu CL, Xiao M, Zhang H, Feng ZQ, Zhao G.
    Zhonghua Yi Xue Za Zhi; 2012 Sep 25; 92(36):2542-5. PubMed ID: 23158794
    [Abstract] [Full Text] [Related]

  • 20. [Transjugular intrahepatic portosystemic shunt in the treatment of complications in portal hypertension].
    Svoboda P, Kantorová I, Brhelová H, Vasícková J, Ochmann J.
    Rozhl Chir; 1997 Feb 25; 76(2):97-102. PubMed ID: 9213934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.